Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-16

Clinical Trial Update: Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium Vivax [NA]

View source ↗

Summary

A clinical trial update investigating tafenoquine combinations to improve radical cure efficacy for uncomplicated Plasmodium vivax malaria; the study is not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tafenoquine (tafenoquine)

Snippet

Sponsor: Walter Reed Army Institute of Research (WRAIR) | Conditions: Uncomplicated P. Vivax Mono-infection | NA | Status: NOT_YET_RECRUITING